How we worked with a multinational Pharma company toward successful market entry in select EU and Latin America countries.
The challenge: Entering a new market. The fine line between "go" and "no-go". A…
How our competitive simulation workshop helped a large pharma in precision oncology, develop its branding strategy for upcoming EU launches.
The Challenge: Formulating a brand strategy for new treatment launches in…
How we collaborated with a medium-sized pharma in the oncology biosimilars space so that they could make the most out of the ESMO conference.
The Challenge: Taking away key industry insights during a large international…
How our strategic intelligence helped a respiratory brand, understand the future landscape and adapt its clinical development program (CDP).
The Challenge: Staying updated with the ever-changing competitive landscape in…
How we allayed a major pharma΄s concerns about Gx entrants and supported unbiased decision-making in the EU market.
The challenge: Estimating the threat of existing and potential generic…
How we helped a mid-size Pharma delve into the competitor landscape and support its brand strategy development.
The challenge: Βuilding an up-to-date biosimilar competitor landscape. A…
How a large cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV.
The challenge: Stimulating conversation around your brand when your competitors…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches.
The challenge: How to prepare when two new competitors enter your space Α…
How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
The Challenge: Understanding how KOLs define the treatment evolution and the…
How we helped a mid-size pharma prepare its sales (SF) and medical teams (MSL) for a competitor's new launch in the migraine prevention space.
The Challenge: Knowing your competitor's new asset market entry timelines.…
How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts.
The Challenge: Mapping prostate cancer stage and identifying key stakeholders…
A major pharma in the COPD / Asthma space strengthened its market position due to competitive intelligence obtained through conference coverage.
The Challenge: Gathering competitive intelligence at conferences Α major…